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CHIP is an E3-ubiquitin ligase that contributes to healthy aging and has been characterised 
as neuroprotective. To elucidate dominant CHIP-dependent changes in protein steady-state 
levels in a patient derived human neuronal model, CHIP function was ablated using gene-
editing and an unbiased proteomic analysis conducted to compare knock-out and wild-type 
isogenic iPSC-derived cortical neurons. Rather than a broad effect on protein homeostasis, 
loss of CHIP function impacted on a focused cohort of proteins from actin cytoskeleton 
signalling and membrane integrity networks. In support of the proteomics, CHIP knock-out 
cells had enhanced sensitivity to induced membrane damage. We conclude that the major 
readout of CHIP function in cortical neurons derived from iPSC of a patient with elevate a-
synuclein, Parkinson’s disease and dementia, is the modulation of substrates involved in 
maintaining cellular ‘health’. Thus, regulation of the actin cytoskeletal and membrane integrity 




CHIP (C-terminus of Hsc70 Interacting Protein) is an E3-ubiquitin ligase originally identified 
by virtue of its ability to interact with Hsc70 (Ballinger et al., 1999). CHIP has historically been 
studied as part of the molecular chaperone network and has been ascribed a direct role in 
determining the balance between protein folding, refolding, aggregation and degradation 
(Connell et al., 2001; Kampinga et al., 2003; Kevei et al., 2017; Marques et al., 2006; Murata 
et al., 2001; Zhang et al., 2015). The degree to which CHIP-mediated ubiquitination of 
unfolded and ‘damaged’ heat shock protein (HSP)-client proteins contributes to the overall 
physiological function of this E3-ligase remains unclear. CHIP-dependent modulation of the 
core chaperone machinery is, however, closely related to the ability of CHIP to protect cells 
and animals from death during thermal stress. When stress is applied, for example in the form 
of hyperthermic conditions, loss of CHIP function leads to apoptosis at the cellular level and 
rapid death in mouse models (Dai et al., 2003). Mechanistically, in response to hyperthermic 
conditions, heat shock transcription factor (HSF1)-containing chaperone complexes can be 
activated by CHIP-dependent mechanisms leading to increasing HSP70 levels (Dai et al., 
2003). De Novo synthesis of HSP70 produces sufficient core chaperone activity to ‘buffer’ the 
cellular environment and prevent irreversible cellular damage (Dai et al., 2003). It is therefore 
not surprising that CHIP deletion in mouse model increases susceptibility to proteotoxic stress 
(Dai et al., 2003; Min et al., 2008). A recent study demonstrated some degree of cell-type 
variability in the response to loss of CHIP function. Whilst fibroblasts from ataxia patients 
(SCAR16), expressing mutant CHIP, had an impaired heat shock response, the response in 
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iPSC-derived neurons from the same patients was relatively unaffected (Schuster et al., 
2020).  
 
Until recently less attention has been paid to what may be described as the non-canonical 
function(s) of CHIP (Landré et al., 2013; Landré et al., 2017; Narayan et al., 2011; Tawo et 
al., 2017). In addition to its HSP-dependent functions, CHIP also has a chaperone-
independent activity, the best characterised substrate for which is the interferon regulated 
transcription factor IRF-1 (Landré et al., 2017; Narayan et al., 2011). The role of CHIP in IRF-
1 regulation, as well as in other key components of the immune system (Kettern et al., 2011; 
Yang et al., 2011), provides insights into the way this E3-ligase contributes to immune 
regulation (Zhan et al., 2017). Studies in animal models have identified additional native 
substrates for CHIP, such as the insulin receptor (INSR) that link directly to organismal health 
(Adachi et al., 2007; Al-Ramahi et al., 2006; Morishima et al., 2008; Ronnebaum et al., 2013; 
Tawo et al., 2017; Zhao et al., 2012). Thus, the main activity of CHIP in unstressed cells 
appears to be closely linked to the maintenance of cellular and organismal ‘health’, through 
the specific regulation of native proteins (Al-Ramahi et al., 2006; Alberti et al., 2002; 
Ronnebaum et al., 2013; Tawo et al., 2017).  
 
In patients with a-synucleinopathies, such as supranuclear palsy, multiple system atrophy, 
dementia with Lewy bodies and Parkinson’s disease (Mark, 2001), CHIP is down regulated by 
sequestration into large a-synuclein aggregates or Lewy bodies (Shin et al., 2005). However 
less is known about the role of CHIP in earlier disease stages Lewy bodies are not detected 
and CHIP remains in soluble. To obtain an a-synucleinopathy model, relevant to early stage 
disease, we used an established patient-derived iPSC line (AST established by (Devine et al., 
2011) as a starting point. This line carries a triplication of the a-synuclein-encoding gene, 
SNCA, which results in four copies of SNCA and a doubling of the mRNA and protein 
expression levels in the absence of large synuclein aggregates or Lewy body structures 
(Devine et al., 2011). Increased steady state levels of a-synuclein is a common background 
across familial and sporadic a-synucleinopathies (Lashuel et al., 2013). CHIP function was 
ablated in AST23 iPSC using gene-editing to generate isogenic cells. Following differentiation 
of the iPSC into cortical neurons – the cell type affected in Lewy body dementia (Gibb et al., 
1989) - an unbiased investigation was undertaken to define dominant steady state proteomic 
changes mediated by CHIP loss, using label-free SWATH-MS (Sequential Window Acquisition 
of all Theoretical Mass Spectra; (Huang et al., 2015; Rosenberger et al., 2014). Target 
discovery was centred around two main criteria: disease-relevance and the identification of 
proteomic changes at early disease stages (in the absence of proteotoxic stress). Systems 
analysis highlights a role for CHIP in maintaining the actin cytoskeleton, as well as providing 




Deletion of CHIP expression in patient-derived iPSC and generation of cortical neurons 
Genetic manipulation of STUB1 was conducted using the CRISPR/Cas9 system. To increase 
the likelihood of an indel knocking out the CHIP gene, a Cas9 and guide RNA (gRNA)-
expressing plasmid was designed to target downstream of the start codon within the first exon 
of STUB1 (Fig 1A). AST23 iPSCs were transfected by electroporation and subsequent viable 
single-cell colonies were validated by quantitative PCR (qPCR) (using primers flanking the 
gRNA as illustrated in Fig. 1B). Both the PCR products and TOPO cloning products presented 
only one sequence, bearing a single base-pair deletion (Fig. 1C). In support of both alleles of 
the potential CHIP KO clone having identical indels, the T7 endonuclease I assay failed to 
recognise and cleave non-homologous dsDNA (Fig. S1). This high precision in DNA editing, 
driven by intrinsic preference for specific indels at target sites, is statistically favoured by the 
presence of the adenine at position -4 from the PAM sequence in the gRNA design, and the 
associated strong bias towards single-nucleotide indels (Chakrabarti et al., 2019). The 
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identical biallelic single base-pair deletion is predicted to cause a frameshift mutation, leading 
to a premature stop codon (Fig. 1D); the transcript would be processed by nonsense-mediated 
decay, abolishing CHIP expression. In fact, the expression of CHIP protein in this KO clone 
was below the level of detection by immunoblot (Fig. 1E). The iPSC AST23 cell panel therefore 
provide isogenic CHIP -/- and CHIP +/+ (both the parental cells - referred to as P - and a control 
CHIP WT line that has been through the gene-editing protocol) cell models. 
 
Moving towards a more disease-relevant model, the isogenic iPSC AST23 lines (CHIP-/- plus 
P and WT CHIP+/+ controls) were differentiated into cortical neurons using an 80-day protocol 
that was optimized in-house. Neural induction from iPSC is triggered by a dual SMAD inhibition 
(Chambers et al., 2009) and is followed by cortical neurogenesis to form the six layers of the 
human cortex (Shi et al., 2012a; Shi et al., 2012b). A schematic of the cortical differentiation 
is shown in Fig. 1F, and the appearance of different populations of cells was monitored by 
quantitative real-time PCR (qRT-PCR) and immunofluorescence (IF), as indicated. As 
expected, we observe a decline in pluripotency and stem-renewal markers (CDK, NANOG, 
OCT4) (Fig. 1G and S2A) and a rise in markers of the primary cortical stem and progenitor 
cells (VIM, NES, OTX2, EMX1 and PAX6) from day 0 to day 11 (Fig. 1G, S2B and S2C). This 
was followed by a rise in markers of the secondary progenitor cells (including FOXG1) and of 
early-born, upper-layer neurons (CTIP2) and late-born, deep-layer neurons (CUX1 and BRN2) 
(Fig. 1G and S2D). Fundamental principles of neural development govern the ability of primary 
cortical stem and progenitor cells and secondary progenitor cells to generate complex 
populations of cortical projection neurons, in a cell-intrinsic manner (Shi et al., 2012a). At day 
50, early-born neurons (TBR1 and/or CTIP2) are predominant in cultures (Fig. 1H and 1I) and 
these persist until day 80 (Fig. S2E) when neurons were harvested for proteomic analysis.  
 
During cortical differentiation cells are subjected to multiple morphogenic factors and undergo 
substantial changes in gene-expression and cell identity. It is therefore not surprising that 
differentiation is associated with some degree of variability, as cell-intrinsic differences 
influence their response to the culturing conditions. Close monitoring of cell morphology and 
expression profile throughout the course of differentiation support a high degree of similarity 
across the cell lines of interest (Fig. 1G-J and S2). This suggests that the CHIP+/+ and CHIP-/- 
iPSC lines have similar differentiation potentials and dynamics, which are key criteria to allow 
adequate comparative proteomics.  
 
Prior to the proteomic analyses, we confirmed that once differentiated isogenic-lines 
maintained differential CHIP expression profiles (Fig. 1K and 1L) in an elevated a-synuclein 
background (Fig. 1M). While the expression of SNCA increases throughout the differentiation 
with the development of neural processes and synapses, STUB1 expression remains largely 
unchanged (Fig. S3).  
 
 
Proteomic analysis of the isogenic cortical neurons 
Once mature (day 80 of the differentiation), cortical neurons were harvested for proteomic 
analysis using SWATH-MS (Fig 2A). Since it has been shown that differences in confluency 
can influence the proteome (Way et al., 2016), cell density was kept consistent between the 
cell lines at all stages of differentiation (Fig. S4 and Fig. 1J). Nonetheless, in effort to consider 
any differences in differentiation status, neurons derived from both P and WT control lines 
(CHIP+/+) were analysed in comparison to the CHIP KO cells (P/KO and WT/KO, Fig. 2B and 
2C, respectively), as well as between each other (P/WT, Fig. 2D). For each cell line, three 
biological replicates were analysed and for each, technical triplicates were performed. The 
most over- and under-represented proteins in each comparative analysis are detailed in 
Tables S1-S3.  
 
The correlation heatmap illustrates how the proteomic datasets derived from CHIP-expressing 
neurons (P and WT) are similar to each other and distinct from the proteome of CHIP KO 
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neurons (Fig. 2E, areas outlined in black). There is limited intra-group heterogeneity (with 
regards to biological and technical replicates – highlighted by squares outlined in grey and 
red, respectively). The difference across CHIP genotypes is pronounced, supporting the 
existence of genotype-specific proteomic changes between these groups. Beyond the 
expected positive linear relationship between P/KO and WT/KO (Pearson correlation index: r 
= 0.7305 and r2 = 0.5337, P value < 0.0001), a subset of proteins identified were consistently 
under- and over-represented. These proteins are more likely to be affected, either directly or 
indirectly, by CHIP status and are less likely to arise from CHIP-independent factors (e.g. slight 
differences in differentiation status). Over- or under-represented proteins are of particular 
interest when they are minimally changed in the P/WT analysis or not detected at all. Of all 
proteins quantified by the SWATH-MS, when focusing on the significantly changed proteins 
only a small fraction (37 proteins) was consistently influenced by the CHIP genotype (Fig. 2G 
and listed in Table S4).  
 
Considering that over- and under-representation of an ionised peptide detected by MS may 
not directly correlate with increased or decreased protein steady state levels at a cellular level, 
being influenced by factors including post-translational modifications and differential ionisation 
potential of proteins, validation is generally recommended. Immunoblot analysis of a selection 
of proteins from the most significantly altered list supports a linear correlation with MS 
identification. Hence, ANXA2, S100A11, HLA-B and SORT1 were all upregulated in whole cell 
lysates from CHIP-/- cortical neurons when compared to WT cells (Fig. 2H-K). In addition, of 
the proteins which meet our ≤ 0.5 and ≥ 2-fold change criterion, both Galectin-1 (0.38-fold) 
and FLNA (0.36-fold) are validated CHIP substrates (Paul and Ghosh, 2015; Wang et al., 
2020). Likewise, previous proteomics identified ANXA5 (0.45-fold), HLA-B (0.22-fold) - as well 
as, FLNA (that here was below the level of detection by immunoblot but significantly changed 
in the MS analysis) - as putative CHIP substrates using an orthogonal substrate identification 
approach (Bhuripanyo et al., 2018). Additionally, AHNAK (0.33-fold) is present in proteomics 
focused on the CHIP-interactome (Kopp et al., 2017). (Note that all fold changes stated are 
derived from our proteomic screen). 
 
 
Pathway analysis of CHIP cortical model  
To decipher cellular functions that may be regulated by CHIP, and how the loss of CHIP- 
changes the steady-state proteome, the gene ontology (GO) terms associated with the P/KO 
and WT/KO SWATH-MS data were defined. Firstly, we used GOrilla software (Eden et al., 
2007; Eden et al., 2009) to obtain GO term IDs and p-values that reflect the probability of their 
association to the P/KO and WT/KO SWATH-MS datasets. Then, significantly associated GO 
terms (p-value < 0.05) derived from either P/KO and WT/KO SWATH-MS datasets were 
graphically represented using REduce + VIsualize Gene Ontology (REVIGO) (Supek et al., 
2011). Interestingly, the majority of the GO terms associated to biological function (Fig. 3A), 
molecular function (Fig. 3B) and cellular component (Fig. 3C) could be described as 
cytoskeletal- and/or membrane-related. GO terms shared between P/KO and WT/KO 
analyses include “cell adhesion”, “biological adhesion”, “actin binding” and “calcium-
dependent phospholipid binding”. Strikingly, “actin binding” and “calcium-dependent 
phospholipid binding” were unique to the proteomics comparing CHIP genotype and were not 
found in the P/WT analysis. 
 
Different pathway analysis software use different statistical models and reference databases. 
Therefore, we sought to enrich our research by incorporating other GO software, including 
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (Szklarczyk et al., 2019) 
and Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang et al., 
2009a, b). The underlying rational is that if a particular GO term is identified by multiple 
software it is more likely to be of biological interest. Likewise, GO terms associated to the 
P/KO and WT/KO SWATH-MS dataset and not to P/WT are of interest. These are listed in 




Protein changes identified in CHIP cortical model are unlikely to reflect general defects in 
protein quality control (QC)  
Given the role of CHIP in proteostasis (Connell et al., 2001; Dai et al., 2003; Kevei et al., 2017; 
Marques et al., 2006; Murata et al., 2001; Qian et al., 2006; Rosser et al., 2007; Zhang et al., 
2015), the impact of CHIP loss-of-function on proteins involved in the regulation of the protein 
triage was assessed, including proteins involved in the ubiquitination system (Table S6) and 
molecular chaperones (Table S7). These were largely unchanged in P/KO, WT/KO and P/WT 
SWATH-MS analyses, arguing against the activation of compensatory mechanisms due to the 
absence of CHIP expression. This is consistent with data from CHIP-/- mouse cells (Morishima 
et al., 2008) and with a study, published during preparation of this manuscript, showing that 
CHIP KO neurons (at day 36) do not have an impaired heat shock response (Schuster et al., 
2020). Notably, the only detected HSP that met the criterion for significant fold-change was 
HSP27 (HSPB1). HSP27 is a known regulator of actin filament stability (Doshi et al., 2009; 
Miron et al., 1991) and was upregulated in KO neurons. Likewise, the only protein involved in 
the ubiquitin system (Table S6) that was significantly changed was FAF-X (USP9X) which has 
been implicated in both Parkinson’s- and Alzheimer’s-disease (Murtaza et al., 2015). The data 
supports the pathway mapping and suggests that the loss of CHIP function may generate a 
specific cytoskeleton-related stress rather than a more general proteotoxic stress phenotype. 
 
 
Membrane- and actin cytoskeletal-related proteomics in different CHIP models 
Since multiple membrane- and cytoskeletal-related GO terms were consistently identified 
when comparing the isogenic WT, P and KO CHIP cell panel, we proceeded to determine 
whether regulation of membrane and cytoskeletal dynamics could be part of the cellular 
functions of CHIP. To begin, the SWATH-MS data obtained from the cortical neurons was 
compared to a reference dataset derived from a model of cell membrane injury (Sønder et al., 
2019) associated with pronounced membrane- and cytoskeleton-related changes. Twelve 
proteins were found to be significantly changed in both the SWATH-MS data comparing CHIP-
expressing neurons to CHIP KO neurons and in the reference dataset, but excluded from the 
P/WT comparison (Fig. 3D). With regards to the shared GO terms, “actin binding” and 
“cytoskeletal protein binding” were identified using GOrilla (Fig. 3E and Table S8) and 
“calcium/phospholipid-binding” and “annexin” using STRING (Fig. 3F). Therefore, the CHIP 
KO cortical neurons and the reference dataset share some proteomic changes, adding 
confidence to the observed membrane- and cytoskeletal-related proteomic changes driven by 
loss of CHIP function.   
We reason that consistently changed processes and pathways across multiple CHIP KO 
models are most likely to have biological relevance. Hence, we compared the MS-based 
proteomics data of the isogenic CHIP cortical neuron model (Fig. 2B-D) with that of other CHIP 
models engineered in-house. This includes the isogenic iPSC (Fig. S5) and SH-SY5Y cells 
(SWATH-MS data deposited in the ProteomeXchange Consortium via PRIDE - PXD016299). 
While the former are undifferentiated, the SH-SY5Y cells are neuronal-like and derived from 
neuroblastoma (Xicoy et al., 2017). The comparative pathway analysis was conducted using 
the IPA software (Fig. 3G).  
Although synaptogenesis signalling pathway and actin cytoskeleton pathway have 
significantly changed z-scores in all datasets of interest, only the actin cytoskeleton pathway 
is consistently associated with a negative z-score in all CHIP-expressing versus CHIP KO 
models (P/KO and WT/KO). Of interest, the proteomic changes observed in the reference 
dataset follow the same trend as the CHIP-expressing versus KO proteomics, while the 
proteomic analysis of CHIP-expressing cortical neurons (P/WT) shows the opposite trend. 
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Hence, we hypothesise that CHIP influences the proteome related to the actin cytoskeleton 
pathway.  
Membrane protein changes identified in CHIP cortical model are not due to general defects in 
membrane QC  
Cytoskeletal-based processes are intimately connected to membrane proteins (Bezanilla et 
al., 2015; Boucher and Mandato, 2015; Fais et al., 2000; Gov, 2018; Jaiswal et al., 2014; 
Sønder et al., 2019). We therefore questioned whether the changes observed were due to a 
broad effect on bulk membrane protein homeostasis, or whether there was a more targeted 
effect of CHIP loss on a subset of membrane-associated proteins. Accordingly, we first sorted 
all cell membrane proteins identified across all SWATH-MS comparisons conducted using 
IPA. The vast majority of membrane proteins identified were similar across all comparisons, 
with only two protein (SORT1 and NCAM1) being consistently identified in the P/KO and 
WT/KO comparisons and excluded from the P/WT analysis (Fig. 4A). Likewise, when focusing 
on membrane proteins with significant fold-changes, most were found in the P/KO and WT/KO 
analyses and excluded from the P/WT analysis (Fig. 4B). However, the proportion of 
significantly changed to unchanged membrane proteins was similar throughout all 
comparisons (Fig. 4C). The data therefore suggest that, whilst CHIP loss does not affect a 
broad cross-section of membrane proteins, it does impact on a focused cohort of membrane 
associated proteins. The membrane subcellular localisation of the INSR has previously been 
shown to be regulated by CHIP, through ubiquitination (Tawo et al., 2017). Accordingly, the 
steady state levels of the INSR are increased in CHIP KO neuronal and SH-SY5Y models 
(Fig. S6). This effect of CHIP in the regulation of membrane proteostasis is associated to its 
role in mediating longevity.     
 
To assess the specific membrane process that could be impacted by loss of CHIP function, 
the biological processes related to these membrane proteins (Fig. 4A and B) were identified 
using DAVID (Fig. 4D and Table S9). Processes that are unlikely to be CHIP-dependent are 
those only found in the P/WT comparison, while processes more likely to be CHIP-dependent 
are exclusively derived from both the P/KO and WT/KO analyses. Only a minority (8%) of 
biological processes fell in the latter group (highlighted in dark grey in Fig. 4D), and most of 
these are related to cell adhesion and the regulation of vesicles – processes that rely on 
cytoskeletal architecture. Furthermore, actin cytoskeleton was the only canonical pathway 
predicted by the IPA software that was consistently and significantly changed in P/KO and 
WT/KO analyses and not in the P/WT comparison (Fig. 4E).  
 
 
CHIP KO cells have a compromised membrane integrity 
We reasoned that if the CHIP-mediated membrane- and cytoskeletal-related proteomic 
changes described above reflected differences in biology, a measurable phenotypic change 
should be detected in the KO cells compared to controls. In order to elucidate any underlying 
differences, membrane and actin cytoskeleton remodelling events were induced by membrane 
injury. It has been shown that extensive actin de- and re-polymerization occurs upon 
membrane damage, in addition to the recruitment of several cytoskeletal and membrane-
binding proteins (Boucher et al., 2019; Boucher and Mandato, 2015; Jaiswal et al., 2014; 
Simonsen et al., 2019). Membrane injury was inflicted using digitonin (an inducer of pores in 
cholesterol-rich regions of the plasma membrane – illustrated in Fig. 4F) and monitored by the 
intracellular leakage of a membrane-impermeable dye (propidium iodide, PI) (Jaiswal et al., 
2014). Here, PI is not only a marker of membrane integrity, but also of cell death (Cummings 
et al., 2012).  
 
Prior to performing damage experiments in isogenic SH-SY5Y cells we first established if the 
protein expression changes seen in CHIP KO neurons were reproduced in the neuroblastoma 
background. Whereas S100A11 did not increase in either the MS analysis or the immunoblots 
in response to the loss of CHIP in SH-SY5Y cells (Fig. S7A), the steady state levels of both 
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ANXA2 and SORT1 where elevate in this cell background (compared to the isogenic WT, Fig. 
S7B&C). The accumulation of ANXA2 and SORT1 in two independent CHIP KO cells models 
of neuronal origin, suggests that they may be core components of the CHIP-regulated 
proteome in neuronal cells.  
 
Following exposure to digitonin both CHIP KO iPSC (Fig. 4G) and SH-SY5Y (Fig. 4H) cells 
were consistently found to accumulate intracellular PI to a greater extent than CHIP-
expressing cells. The result suggests increased membrane ‘leakiness’ and sensitivity to 
membrane damage in both cell lines. CHIP KO iPSC also incorporated more intracellular PI 
than the controls prior to injury, highlighting potential differences in membrane integrity under 
basal conditions. CHIP KO SH-SY5Y cells were rescued by the stable expression of a K30A 
mutant CHIP (Fig.4H) – this mutant no longer binds HSP70 but retains some E3-ligase activity 
(Narayan et al., 2015). In contrast, no rescue was seen with an E3-ligase dead mutant of CHIP 
(H260Q; Fig.4H). The latter result supports a specific role for the E3-ligase function of CHIP 
in membrane integrity.  
 
Membrane injury was next induced by a UV-ablation laser and monitored by live-imaging using 
an membrane-impermeable dye FM1-43 (Jaiswal et al., 2014) added to the culture media (Fig. 
4I). Supporting the digitonin data, CHIP KO SH-SY5Y cells incorporated more FM1-43 dye 
than WT cells following laser-induced injury (Fig. 4J&K). Of note were differences in the cell 
morphology and behaviour upon injury: CHIP KO cells migrated more, retracted their 
projections and adopted a rounded phenotype post-injury, while WT cells remained largely 
unchanged post-injury (Fig. 4J).  
 
Together, phenotypic data reveal differences in membrane and cytoskeletal homeostasis in 
the absence of CHIP function. At a cellular level, CHIP KO cells have a compromised 
membrane integrity, suffering from increased permeability under basal conditions and have 




Until relatively recently the prevailing hypothesised for the function of the CHIP E3-ligase has 
almost been exclusively explained through its ability to bind core components of the molecular 
chaperone machinery and, in doing so, actively take part in the degradation of HSP-client 
proteins (Dickey et al., 2007; Joshi et al., 2016; Kampinga et al., 2003; Marques et al., 2006; 
Murata et al., 2001; Paul and Ghosh, 2015; Zhang et al., 2005). More than 226 diverse putative 
substrates have been identified for CHIP (Bhuripanyo et al., 2018; Joshi et al., 2016; Marques 
et al., 2006), with the vast majority linked to HSP70-binding and substrate degradation. This 
view was supported by a recent study comparing iPSC-derived neurons from SCAR16 
patients (with various STUB1 mutations) to those from healthy individuals. The proteomic 
changes identified in the Schuster et al. (2020) study were primarily associated with oxidative 
and proteotoxic stress. In the current study we were able to uncouple the role of CHIP in 
oxidative stress and protein QC from its non-canonical activities by using isogenic cells in an 
early stage disease background. Our aim was to identify processes that are involved in CHIP-
dependent neuroprotection at early disease stages, when wild-type CHIP is still active, in 
expectation that these become less significant at later disease stages and disease 
progression is favoured, for example when CHIP activity is down-regulated due to 
sequestration into Lewy bodies (Shin et al., 2005). What we found was that loss of CHIP 
function in the AST23 background produced detectable steady state changes in a relatively 
focused cohort of proteins (Fig. 2B&C). Proteins that were most significantly changed place 
the ligase as a determinant of actin cytoskeleton function and homeostasis of specific 
membrane proteins. A role for CHIP in membrane biology is of interest as membrane 
homeostasis has recently become a subject of investigation in a-synucleinopathies (Bozelli et 
al., 2021; Dettmer et al., 2017; Rovere et al., 2019) and, more generally, in neurodegenerative 
conditions (Bezprozvanny and Hiesinger, 2013; de Groot and Burgas, 2015; Marin, 2013). 
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At the single cell level, the repair of membrane structural damage is an active process that 
requires the coordinated manipulation of both the cell’s cytoskeletal and membrane 
compartments (Boucher et al., 2019; Boucher and Mandato, 2015). This is evident from the 
proteomics analysis of the reference database (a comparative proteomic analysis of a cell 
model of membrane injury described in (Sønder et al., 2019). Of note, proteins with 
membrane- and cytoskeletal-binding properties were not only found to be significantly 
enriched in this dataset (Fig. 3E & F), but also across all of the CHIP WT/KO models (Fig. 
3G). Proteins significantly changed both in response to CHIP loss in neuronal cells and to 
membrane injury (the reference database) belong either to the membrane repair protein 
machinery (including ANXA5 (Bouter et al., 2011) and ANXA7 (Sønder et al., 2019)) or the 
cytoskeleton network (ACTN1 (Naumanen et al., 2008), FLNA (Yue et al., 2013), TPM1 (Janco 
et al., 2016) and MAP4 (Kitazawa et al., 2000)) (Fig. 3D). Similarities in proteomic changes 
derived from loss of CHIP and exposure to membrane stress opens the question whether 
altered membrane homeostasis may be of relevance in human diseases associated to CHIP 
loss-of-function.  
 
Membrane injury triggers extensive cytoskeletal remodelling. Specifically, the resultant 
calcium influx drives actin remodelling (Boucher and Mandato, 2015), protein-driven 
modulation of the membrane and the recruitment of cytoskeletal-remodelling proteins to 
facilitate wound closure (Boye et al., 2018; Jaiswal et al., 2014; Simonsen et al., 2019). Apart 
from its role in modulating membrane tension, cytoskeleton remodelling is also required for 
endocytosis- and exocytosis-mediated repair (Boucher and Mandato, 2015; Cooper and 
McNeil, 2015). The integrity of the cytoskeleton and its ability to reorganise rapidly in response 
to external and internal stimuli is key for normal cell function (Kaminska et al., 2011). It has 
been reported that E3 ligases can modulate actin cytoskeleton dynamics (reviewed in 
(MacGurn et al., 2012), these include NEDD4 (Stawiecka-Mirota et al., 2008), MURF2 
(Silvestre et al., 2019), RSP5 (Kaminska et al., 2011), OZZ (Bongiovanni et al., 2012) and 
CLB (Watanabe et al., 2013). Although the role of the ubiquitin-proteasome system in 
membrane repair via modulation of the cytoskeleton has not been investigated extensively, it 
has been proposed (Cai et al., 2009; Ibañez-Vega et al., 2019; Watanabe et al., 2013). For 
example, ubiquitin-dependent, chaperone-assisted selective autophagy (CASA) may be 
related to membrane fragility and to the cytoskeletal changes observed in our model due to 
the absence of CHIP. CASA is a BAG3-dependent process that recruits HSP70 and CHIP to 
form active complexes (Arndt et al., 2010). FLNA, an actin and membrane protein cross-linker, 
when released from actin filaments after rounds of muscle contraction is degraded in the 
lysosomes via CASA. Interestingly, FLNA has been previously validated as a CHIP substrate 
(Arndt et al., 2010; Paul and Ghosh, 2015) and was identified in our dataset. Although a mutant 
of CHIP (K30A), which cannot bind to HSP70 (Narayan et al., 2015), complements the 
membrane-damage phenotype in CHIP KO SH-SY5Y cells (Fig. 4H), we can’t rule out a role 
for CASA in explaining the molecular and cellular phenotype observed, as the precise 
architecture of the complex and the mechanism of CHIP recruitment remains to be 
determined.  
 
Membrane protein homeostasis is of utmost importance to maintain membrane integrity and 
cell function (Kevei et al., 2017). Plasma membrane QC mechanisms are not only employed 
during membrane “remodeling” in the aftermath of injury (to remove damaged components 
and restore adequate protein) (Boucher and Mandato, 2015; Cooper and McNeil, 2015; 
Davenport et al., 2016; Häger and Nylandsted, 2019; Moe et al., 2015), but also as part of 
housekeeping functions under basal conditions (Meacham et al., 2001; Morishima et al., 2008; 
Tawo et al., 2017; Zhao et al., 2013). Although the underlying QC mechanisms for the 
membrane are still largely unknown, ubiquitination-based mechanisms have been proposed 
(MacGurn et al., 2012). Accordingly, there is growing evidence for the role of CHIP in 
membrane protein biology, such as in the regulation of the misfolded fibrosis transmembrane-
conductance regulator (CFTR) (Meacham et al., 2001). CFTR-regulation is part of the 
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canonical functions of CHIP, being HSP-dependent (Okiyoneda et al., 2010). However, more 
recent evidence points to a role for CHIP in the regulation of folded membrane proteins, 
including GR (Morishima et al., 2008) and INSR (Tawo et al., 2017). The latter, however, only 
occurs in the absence of cellular stress (Tawo et al., 2017). Also recently, it has been shown 
that CHIP can be transiently recruited to cellular membranes, having affinity for specific 
phospholipid species (Kopp et al., 2017). CHIP localisation to membranes is shown to be 
HSP70-independent, again pointing to a non-canonical function for CHIP in membrane protein 
regulation.  
 
Here, we found that loss of CHIP function in neuronal cells leads to changes in the MS-profile 
that were indicative of steady state changes in a specific subset of membrane-associated 
proteins (Fig. 4B), whereas the bulk of membrane proteins were unaffected by loss of CHIP 
(Fig. 4C). The data therefore suggest a role for CHIP in the regulation of specific membrane 
components rather than a general loss of integrity due to more widespread defects in 
membrane QC. Interestingly, the majority of the membrane proteins influenced by CHIP status  
are involved in maintaining membrane integrity, having established roles in membrane repair 
(ANXA2, ANXA6, ANXA5, ANXA7 (Draeger et al., 2011) and Zyxin (Lecroisey et al., 2013)) – 
or a putative role in exocytosis-mediated membrane repair (Borgonovo et al., 2002; Cai et al., 
2009; Cooper and McNeil, 2015), namely CADPS (Cisternas et al., 2003) and SYNGR1 
(Sugita et al., 1999) – and in regulation of the actin-cytoskeleton (ITGB1 (Otey et al., 1990), 
PALLD (Yadav et al., 2016), EPB41L3 (Baines et al., 2014), ENAH (Krause et al., 2003), VCL 
(Le Clainche et al., 2010) and SYN2 (Bloom et al., 2003) (Fig. 4B). Thus, by controlling 
membrane properties (directly or indirectly), CHIP may influence cytoskeleton and membrane 
dynamics. This is illustrated by the finding that CHIP KO cells were consistently more sensitive 
to membrane stressors (Fig. 4G-K) and had defective repair kinetics (Fig. 4K). Thus, the 
induction of membrane stress revealed a significant phenotypic consequence of loss of CHIP 
function. A president for how E3-ligases can impact on membrane homeostasis can be found 
from studies on Rap5. Loss of Rap5 ubiquitin ligase function leads to impaired QC of 
membrane proteins, causing their accumulation at the plasma membrane and loss of 
membrane integrity  (Zhao et al., 2013). However, our data suggest a role for CHIP in the 
regulation of specific membrane components rather than a general loss of integrity due to 
more widespread defects in membrane protein QC. 
 
The intimate relationship between actin cytoskeleton and membrane dynamics is clear. 
However, how these are regulated to ensure adequate membrane repair responses and 
overall maintenance of membrane integrity and cell function is less clear. Data presented 
suggest that CHIP can influence actin cytoskeleton signalling and membrane integrity in 
different cell models, including cortical neurons. Given the growing link between plasma 
membrane QC, membrane integrity and neurodegeneration (Naudí et al., 2013; Shrivastava 
et al., 2017; Wong-Ekkabut et al., 2007; Zhao et al., 2013), as well as cytoskeletal defects and 
neurodegeneration (e.g. tauopathies) (Bamburg and Bloom, 2009), understanding how CHIP 
influences both the cytoskeleton and plasma membrane integrity could provide insights into 
disease mechanisms. In addition, identification of non-canonical activities of CHIP may help 
to explain how CHIP is neuroprotective and suggest how mutation or sequestration of CHIP 
impacts on cognitive health.  
 
Limitations of the Study 
The amount of material we were able to generate from iPSC-derived cortical neurons was 
limiting. Therefore, the mass spectrometry analysis likely detected the dominant steady state 
changes in proteins modulated by CHIP and under-represented proteins present at very low 
cellular concentrations. For example, we were not able to detect IRF-1, a well characterised 
CHIP substrate, which is expressed at very low levels in cultured cells. Nonetheless, to limit 
this under-representation, analysis was conducted using the data-independent mode. In 
addition, our study was designed to measure changes in protein levels rather than 
identifying CHIP-dependent changes in the ubiquitinome. As a consequence, the proteins 
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found to be differentially present in CHIP wild-type and KO neurons are not necessarily 
CHIP substrates but could be modulated indirectly by CHIP. Following on from this, CHIP 
substrates subjected to ubiquitination that is not linked to changes in protein level, for 
example those modified with K63-linked polyubiquitin, would not have been identified.  The 
iPSC-derived cortical model used also has some inherent limitations. Firstly, both the 
genetic editing and the cortical differentiation are subjected to clonal variability. Hence, 
multiple CHIP cell models were investigated and only consistent changes were considered. 
Furthermore, our isogenic CHIP iPSC panel was restricted to a single CHIP KO cell line due 
to the difficulties in generating viable CHIP KO clones in the AST23 background. Finally, our 
ability to carry-out membrane damage experiments in cortical neurons, as opposed to iPSC 
or SH-SY5Y cells, was limited as even the wild-type neurons were extremely sensitive to the 
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Figure 1. Isogenic CHIP patient-derived iPSC and cortical models 
A) Using conventional cloning, the guide RNA (gRNA) targeting the gene of interest 
(STUB1) was inserted into the LentiV2 CRISPR vector carrying the Cas9 gene. Cells 
(cycling iPSC and undifferentiated SH-SY5Y) were transfected with this plasmid using 
nucleofection. 
 
B) The gRNA used was designed to target a 20-nucleotide region (in green) within the 
first protein-coding exon of the STUB1 gene, exon 1. The PCR primers used for 
screening purposes flanked this region (shown in magenta) 
 
C) Sequencing of the PCR-amplified STUB1 locus to which the gRNA targets revealed a 
single base-pair deletion (highlighted in red) in both alleles.  
 
D) Protein sequence of the mutant CHIP (p.N65TfsX7) which would be encoded due to 
the occurrence of the indel. Such frameshift and nonsense mutations are predicted to 
result in the deletion of CHIP by nonsense mediated decay.  
 
E) Steady state levels of CHIP protein in the isogenic CHIP patient-derived iPSC lines, 
detected by SDS-PAGE/immunoblot. 
 
F) Schematic of the cortical differentiation protocol starting with iPSC and finishing at day 
80 with both early- and late-born neurons formed. Colours indicate the different 
culturing conditions: differentiation media (N2 supplement and B27 supplement with 
retinoic acid) (grey), dual SMAD inhibition (SB and LDN) (blue), and neurotrophic 
factors (red). Throughout the differentiation, cells are either lifted as single cells 
(indicated by the hash) or as clumps (indicated by the asterisks).  
 
G) The temporal specificity of the expression of different neuronal markers was assessed 
by qRT-PCR (normalised by TATA binding box protein (TBP) gene expression) in our 
isogenic CHIP model throughout the differentiation process. First, pluripotency 
markers (NANOG is shown) decline by day 11, while markers of cortical stem and 
progenitor cells (including the neuroectodermal marker, PAX6) increase. Once 
cultures are more mature, markers of both deep-layer (CTIP2) and upper-layer (CUX1) 
cortical neurons can be detected. Bars represent averages and error bars represent 
standard deviations of three technical replicates. Results are representative of two 
independent cortical differentiations.  
 
H) Representative immunofluorescent images showing the expression of CTIP2 and 
TBR1, markers of early-born, deep-layer neurons at day 50 of differentiation in CHIP 
KO and WT cultures. Scale bar, 100 μm. 
 
I) Corticothalamic projection neurons of layer 6 express both TBR1 and CTIP2, while 
corticospinal motorneurons of layer 5 only express CTIP2. To assess the identity of 
the cultures, neurons expressing TBR1 and/or CTIP2 were quantified. No difference 
was detected in neuronal subpopulations across CHIP genotypes (Student’s t-test) 
and the percentage of deep-layer neurons obtained exceeds that reported by (Shi et 
al., 2012b) (indicated by the dashed lines).  
 
J) Phase contrast images of the isogenic CHIP cortical model at the end of the 
differentiation process (day 80). The morphology and confluency across cell lines is 
highly similar. Scale bars, 200 μm. 
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K) Steady state levels of CHIP protein in the isogenic CHIP cortical model, detected by 
SDS-PAGE/immunoblot. 
 
L) Representative immunofluorescent images showing the expression of CHIP in mature 
CHIP KO and WT-expressing cortical neurons (at day 80 of differentiation). Scale bar, 
100 μm. 
 
M) Representative immunofluorescent images showing the expression of a-synuclein and 
b(III)-tubulin in mature CHIP KO and WT-expressing cortical neurons (at day 80 of 




Figure 2. Effect of CHIP expression on the proteome of patient-derived cortical neurons 
A) Rational of SWATH-MS analysis of CHIP-expressing cortical neurons (the 
CRISPR/Cas9 control, WT, and unedited parental line, P) and CHIP KO cortical 
neurons.  
 
B-D) SWATH-MS analyses of the CHIP cortical neuronal model: P/KO (B), WT/KO (C) and 
P/WT (D). Cut off criteria (≤0.67 and ≥1.5 fold change) are represented by the dashed 
lines. Proteins that do not meet this fold change criteria are colour-coded in grey and 
does that do are in red. Over-represented proteins in the CHIP KO sample compared 
to WT have negative log (fold change), while under-represented proteins have positive 
values. The top 11 most under- and over-represented proteins that were significantly 
changed (P < 0.05) are annotated.  
 
E) Correlation heatmap of the SWATH-MS analysis of CHIP-expressing cortical neurons 
(P and WT) and CHIP KO cortical neurons. All biological triplicates and technical 
replicates are included. Biological replicates (denoted as P1-3, WT2, 5, 8 and KO 3, 
6, 9 and indicated by the three squares outlined with grey) correlate with each other 
(in particular the KO replicates, P2 with P3 and WT2 with WT5), supporting the 
existence of limited intra-group variability. Likewise, technical triplicates (denoted as 
“1, 2 and 3”) show a very high correlation within each biological replicate (squares with 
red outline). The two areas outlined in black highlight high correlation across biological 
samples (i.e. all KO samples and most WT and P samples). 
 
F) Correlation of the comparative proteomics analyses of CHIP-expressing cortical 
neurons versus CHIP KO cortical neurons (P/KO and WT/KO). Log2 fold changes of 
proteins identified in both SWATH-MS experiments are plotted. The Pearson 
correlation: r2 = 0.5337. 
 
G) Overlap of significantly changing proteins (with fold changes ≤0.5 and ≥2) identified in 
the different comparative proteomics analyses, both across neuronal cultures of the 
same CHIP genotype (P/WT in blue), and different CHIP genotypes (P/KO and 
WT/KO, in red and grey). 
 
H) HLA-B expression in cortical neurons of different CHIP genotypes. Nuclei were stained 
with DAPI. Images are z-projections (maximal projection) from stacks. Scale bar, 10 
μm. 
 
I) Steady state levels of ANXA2 protein in the isogenic CHIP cortical model, detected by 
SDS-PAGE/immunoblot. 
 








Figure 3. Pathway analysis of the proteome of the neuronal CHIP model and its 
similarities to other CHIP cell models and a model of membrane injury 
A-C) The proteomic changes between CHIP-expressing cortical neurons and CHIP KO 
cortical neurons (P/KO and WT/KO) were analysed by GOrilla. GO terms derived were 
were plotted by REduce + VIsualise Gene Ontology (REVIGO). GO terms shown are 
related biological processes (A), molecular functions (B) and cellular components (C) 
and each term is colour-coded based on statistical significance (log10(p-value)). For 
GO terms found in both P/KO and WT/KO, averages of the p-values were considered.  
 
D) Proteomic changes of the neuronal CHIP model share similarities with a cell model of 
membrane injury. Overlap of significantly changing proteins (with fold changes ≤0.67 
and ≥1.50) identified in the comparative proteomics analyses of the neuronal CHIP 
model (both across neuronal cultures of the same CHIP genotype (P/WT), and 
different CHIP genotypes (P/KO and WT/KO)) and that of the injury model (annotated 
as “reference”). Twelve proteins were found in common in the analyses across 
different CHIP genotypes and the reference dataset.  
 
E) Overlap of the biological processes identified from the different comparative 
proteomics analyses (P/WT, P/KO and WT/KO) and those identified from the reference 
dataset. Data was derived from the GOrilla pathway analysis. Two processes (calcium-
dependent phospholipid binding and actin binding) were identified in common from the 
analyses across different CHIP genotypes and the reference dataset. (Additional 
information regarding p-values and enrichment scores for each GO term as well as the 
GO terms not included in the figure can be found in Table S5).   
 
F) Gene ontology analysis by STRING of the comparative proteomics of neuronal CHIP 
models (WT/KO and P/KO) and the reference dataset revealed similarities in molecular 
functions regarding calcium/phospholipid binding and annexin.  
 
G) Comparative pathway analysis of the comparative proteomics of multiple CHIP cell 
models and the membrane injury cell model (reference dataset), using Ingenuity 
Pathway Analysis. The heatmap shows the pathways that are most common across 
the datasets (-log(p-value) > 1.3), along with their z-score, which reflects the predicted 
activation state of the predicted pathway (a positive/negative z-score indicates 
activation/inhibition). Results are derived from proteomic analyses of biological 




Figure 4. Changes in membrane proteins and actin cytoskeleton dynamics across CHIP 
models 
A) Membrane proteins identified in the comparative proteomics analyses of the neuronal 
CHIP model were sorted by Ingenuity Pathway Analysis (IPA). The vast majority were 
similar across all comparisons, with only two protein (SORT1 and NCAM1) being 
consistently identified in the P/KO and WT/KO comparisons and excluded from the 
P/WT analysis.  
 
B) Significantly changed membrane proteins (with fold changes ≤0.67 and ≥1.50) found 
in the P/KO and WT/KO analyses and excluded from the P/WT analysis. 
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C) The membrane proteins identified in the SWATH-MS analyses of the neuronal CHIP 
model and sorted by IPA were grouped into unchanged and significantly changed 
(under- and over-represented when having a fold change ≤0.67 and ≥1.50, 
respectively). 
 
D) Overlap of biological processes associated to the significantly changed membrane 
proteins across the isogenic CHIP neuronal model. Pathway analysis was conducted 
by Database for Annotation, Visualization and Integrated Discovery (DAVID). 
Statistical details of the GO terms associated to significant membrane proteins 
identified in both P/KO and WT/KO in Table S7.  
 
E) Heatmap showing the signalling cascades predicted by the IPA to be the most 
significantly changed across neuronal model with differential CHIP expression. 
Significantly associated pathways (-log(p-value) > 1.3) and have a z-score that reflects 
their predicted activation state (a positive/negative z-score indicates 
activation/inhibition). 
 
F) Schematic of the mode of action of digitonin-induced membrane injury at cholesterol-
rich regions. Upon injury and the subsequent influx of calcium, actin becomes 
depolarised. This triggers the recruitment of calcium-dependent phospholipid-binding 
repair proteins and induces substantial cytoskeletal remodelling for repair.  
 
G&H) iPSC (G) and undifferentiated SH-SY5Y (H) of different CHIP genotypes were 
incubated with increasing doses of digitonin. Other than CHIP KO cells and those 
expressing WT CHIP, undifferentiated SH-SY5Y expressing the E3 ligase-dead CHIP 
mutant (H260Q) or the chaperone-dead CHIP mutant (K30A) were also included. 
Injured and control cells were incubated with propidium iodide and cell-permeable 
Hoechst, allowing quantification of PI+ cells in a population of cells (reflective of 
increased permeability). Three biological replicates were included per condition and 
cell line. Bars represent mean ± SD. Two-way ANOVA, P < 0.05, **P < 0.005, ***P < 
0.0005, ****P < 0.0001. 
 
I) Schematic of the repair kinetics assay using UV laser-induced injury and a cell 
impermeable dye, FM1-43. Damage to the cell membrane results in a gradual 
intracellular accumulation of FM1-43 dye.  
 
J) UV laser-induced injury (represented by the crosses) caused undifferentiated SH-
SY5Y cells to incorporate the cell impermeable dye FM1-43 in the cell bodies in a time-
dependent manner. The outline of the cell bodies before (red) and after (yellow) injury 
are shown. Cells that have migrated in the aftermath of the injury are highlighted by 
the red arrows. Representative images of CHIP WT and KO cells at pre-injury, injury 
and 180s-post injury are shown.  
 
K) Undifferentiated SH-SY5Y CHIP KO cells incorporate more of the FM1-43 dye than 
the CHIP KO cells. The fluorescence intensity (F) within cell bodies was quantified 
over time and normalised by the pre-injury fluorescence (FD/F0). Averages were 














Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Kathryn Ball (kathryn.ball@ed.ac.uk). 
 
Materials availability 
This study generated a CHIP KO iPSC line carrying a triplication of the SNCA gene (AST23-
CHIPKO) and differentiated this iPSC line into mature cortical neurons. The isogenic CHIP -/- 
and CHIP +/+ iPSC lines are available.   
 
Data and code availability 
The published article includes all datasets generated or analysed during this study: 
Table S1 and Data S1: The most under- and over-represented proteins (Table S1) or all 
proteins identified (Data S1) in the SWATH-MS analysis comparing parental cortical neurons 
(genetically unedited) to CHIP KO cortical neurons.  
Table S2 and Data S2: The most under- and over-represented proteins (Table S2) or all 
proteins identified (Data S2) in the SWATH-MS analysis comparing CHIP-expressing cortical 
neurons (derived from a CRISPR/Cas9 control clone) to CHIP KO cortical neurons.  
Table S3 and Data S3: The most under- and over-represented proteins (Table S3) or all 
proteins identified (Data S3) in the SWATH-MS analysis comparing CHIP-expressing cortical 
neurons (the parental line and the CRISPR/Cas9 control line).  
Data S4: All proteins identified in the SWATH-MS analysis comparing CHIP-expressing iPSC 
(derived from a CRISPR/Cas9 control clone) to CHIP KO iPSC.  
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository with the dataset 
identifier PXD021404. 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Cell lines 
AST23 (female): iPSC cells were cultured on Laminin 521-coated plates (Biolamina) for 
routine culturing and maintained on iPS-Brew XF media (130-104-368, StemMACS, Miltenyi 
Biotech Inc.), 37ºC and 5% CO2 in a humidified atmosphere. iPSC were passaged using 0.5 
mM EDTA (UltraPure 0.5 M EDTA, pH 8, 15575020, Gibco), diluted in dPBS without calcium 
and magnesium (D8537, Sigma). This line was previously authenticated by SNP and gene 
expression microarray (refer to Devine et al., 2011).  
 
SH-SY5Y (female): Human neuroblastoma cells were maintained on DMEM (41965-039, 
Gibco), 10% fetal bovine serum (10270-106, Gibco), 37ºC and 5% CO2 in a humidified 
atmosphere. When 70-80% confluence, cells were passaged using trypsin (0.05% trypsin + 
0.02% EDTA, Gibco, 15090).  
 
All cell lines were routinely tested for mycoplasma using the Luciferase-based MycoAlertTM 
detection kit (Lonza) and cell authentication was performed by morphology and molecular 




Generation of CHIP KO iPSC using CRISPR/Cas9 technology 
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The gRNA was designed to target downstream of ATG within the first coding exon (exon 1) of 
STUB1, increasing the likelihood of an indel mutation knocking out CHIP protein. The guide 
sequence used is GGCCGTGTATTACACCAACC GGG (PAM sequence underlined). 
According to the MIT software, it has a quality score of 94% and predicted to have 30 off-
target sites, of which 7 are located in genes. Previously, this gRNA was inserted into a LentiV2 
backbone containing the Cas9 gene and successfully generated homozygous CHIP KO SH-
SY5Y cells (Nita et al., 2020, in preparation).  
 
AST23 iPSC were first lifted with Accutase (A6964, Sigma) and incubated in culturing media 
supplemented with 10 μM Y27632 dichloride (1254, R&D, Tocris) to promote survival. Cells 
were transfected using the Human Stem Cell Nucleofector (VPH-5012, Lonza) according to 
the manufacturer’s instructions. Electroporation was performed with the B-016 program in a 
NucleofectorTM 2b Device (AAB-1001, Lonza). Cells were plated at low density on Laminin 
521-coated plates (Biolamina) and incubated with the culturing media supplemented with 10 
μM Y27632 dichloride (1254, R&D, Tocris) for two days.  
 
Once single cells grew into small colonies they passaged onto individual wells within a 96-well 
plate. Prior to this, cells were treated for 2 h with culturing medium supplemented with 10 μM 
Y27632 dichloride. Cells were treated with 250 U/ml of Collagenase Type IV (17104019, 
Gibco) until colonies begin to detach. Single colonies were picked manually, as single cell 
sorting tends to be too stressful for iPSCs. Picked colonies were maintained in culturing 
medium was supplement with 0.5 U/ml Penicillin + 500 ng/ml Sreptomycin (15140122, Gibco) 
and 10 μM Y27632 dichloride. Once clones grew from the 96-well plate, they were passaged 
into incrementally increasing plates until they were validated (by immunoblotting, 
immunofluorescence and sequencing) and cryopreserved. Sequencing data obtained was 
analysed using SnapGene to identify indels within the STUB1 gene of clones derived from 
CRISPR/Cas9-based gene editing. 
  
 
Polymerase chain reaction (PCR) genotyping 
Chromosomal DNA was extracted from frozen cell pellets using the Gentra Puregene Cell kit 
(Qiagen) following manufacturer’s instructions. STUB1 gene amplification was performed 
using the high fidelity Pfu DNA polymerase according to manufacturer’s instructions and both 
forward (AGAACGAGGGTGCGATGC) and reverse (GATGTCGTCCCCGAAGTTCA) 
primers. PCR cycling was performed using the Agilent SureCycler 8800 machine and DNA 




PCR products obtained using Taq DNA polymerase (M1661, Promega) were sub-cloned into 
a vector (pCR 2.1-TOPO TA) optimised for high efficiency transformation, using the TOPO-
TA Cloning Kit for Subcloning (450641, Invitrogen) according to the manufacturer’s 
instructions. DH5α competent cells were transformed and the DNA of single colonies was 
extracted using the QIAprep Spin Miniprep Kit (27104, Qiagen) and sequenced. 
 
 
T7 Endonuclease I assay 
PCR products with STUB1 amplified were subjected to the T7 endonuclease I assay (New 
England Biolabs) according to manufacturer’s instructions. The reactions were 
electrophoresed in a 1% agarose gel with SYBR®Safe DNA Gel Stain (Invitrogen), which was 
also loaded with the Quick-Load 100 bp DNA ladder (New England Bioscience).  
  
 
Quantitative Reverse Transcription PCR (qRT-PCR) 
 23 
RNA was isolated using the Epicentre MasterPureTM Complete DNA and RNA Purification 
Kit (Epicentre, MC85200) and treated with riboguard RNAse inhibitor (Invitrogen, 10777019) 
and DNAse I (New England Biolabs), according to the manufacturer’s instructions. cDNA was 
synthesised from 1 μg of DNAseI-treated RNA using the M-MLV Reverse Transcriptase (200 
units/μl) (28025013, Invitrogen). RT-qPCR was performed using the Universal Probe Library 
(UPL) (Roche). The Roche UPL Assay design centre was used to design the primers (when 
available, these were intron-spanning) with specific UPL probes for each gene (Table S10). 
Reactions (10 μl) containing cDNA, primers, UPL probe, LightCycler® 480 UPL Probe Master 
mix (Roche) and PCR water were performed in 386-well plates as described by the 
manufacturer’s instructions. For each primer used three technical replicates were included. 
The data were normalised to the levels of TATA-binding protein (TBP).  
 
 
SDS-PAGE and Immunoblotting 
For immunoblotting, cells were harvested by scrapping (after being washed with PBS) and 
pellets were lysed with 8M urea, 50 mM Hepes pH 8, 100 mM KCl, 1mM DTT and 0.2% Triton 
X-100. Protein concentration of lysed samples was quantified using Protein Assay Dye 
Reagent (Bio-Rad), according to the manufacturer’s instructions. Proteins were resolved on 
12% polyacrylamide gels and transferred onto 0.2 μM nitrocellulose membranes (Amersham 
Protran, GE Healthcare). Immunoblots were blocked with 5% skimmed milk powder in PBS 
containing 0.1% Triton X-100 and then incubated with either an in-house primary antibody 
against CHIP, anti-ANXA2, anti-S100A11, anti-SORT1 or anti-b-actin diluted in the block 
solution for 1h at room temperature shaking. The secondary antibody used was anti-mouse 
or anti-rabbit and conjugated with horseradish peroxidase also diluted in the block solution. 




Cells were fixed with 4% PFA and blocked with 2% donkey serum (Sigma) in PBS with 0.1% 
Tween-20. Primary antibodies used were a-synuclein, b(III)-tubulin, CHIP, CTIP2, TBR1, 
Pax6 and HLA-B. Secondary antibodies used include anti-mouse A488, anti-mouse IgG2b 
A647, anti-mouse A555, anti-rat A488 and anti-rabbit A555, alongside DAPI. Cells were 
imaged using the Axio Imager (Zeiss) and the microscope hardware was controlled by 
Micromanager Software (μManager). ImageJ was used to create maximal projections from z-
stacks of images. 
 
 
Cortical differentiation from iPSC 
The dual SMAD inhibition protocol used for neural induction was based on published protocols 
(Chambers et al., 2009; Shi et al., 2012a; Shi et al., 2012b) and optimised for our iPSC model. 
Cells were plated at 80,000 cells/cm2 on laminin 111-coated plates (Biolamina) and treated 
with 10 μM Y27632 dichloride (1254, R&D, Tocris) for 48h. Once seeded they were maintained 
in differentiation media containing DMEM/F12 (21331-020, Gibco):Neurobasal media (21103-
049, Gibco) in 1:1 ratio, B27 supplement with retinoic acid (17504044, Gibco), N2 supplement 
(17502001, Gibco) and 2mM L-glutamine (25030-024, Gibco). For 11 days, iPSCs were 
treated with 10 μM SB431542 (616461, Merck Chemicals, Calbiochem) and 100 nM LDN 
(130-103-925, Miltenyi Biotech) and the media was changed daily. 
 
For cortical neurogenesis, cells were passed at day 11 and plated onto laminin 111-coated 
plates (Biolamina) in a 1:1.5 ratio. For such, cells were incubated with Collagenase Type IV 
(250 U/ml, 17104019, Gibco) until they detach as a monolayer and then triturated by pipetting 
until small aggregates form. After washes, cells were incubated with differentiation media 
supplemented with 10 μM SB431542 (616461, Merck Chemicals, Calbiochem), 100 nM LDN 
(130-103-925, Miltenyi Biotech) and 10 μM Y27632 dichloride (1254, R&D, Tocris) for 24h. 
The media was replaced every 2 days and the Y27632 dichloride supplement is no longer 
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added. Once neural rosettes form, at day 17 of the differentiation, cells were passaged again 
as before, but instead they were plated in a 1:2 ratio. The final passage was performed at day 
25, once neurons first begin to accumulate at the outside of rosettes. To dissociate into single 
cells, cultures were incubated with Accutase (A6964, Sigma) until the cells detached from the 
plate. Lifted cells were then passed through a 40 µm cell strainer to obtain single cells.  These 
were seeded on laminin 111-coated plates (Biolamina) at 35,000 cells/cm2 (for 
immunofluorescence) and 80,000 cells/cm2 (for RT-qPCR, immunoblotting and SWATH-MS), 
and incubated with differentiation media supplemented with 10 μM Y27632 dichloride (1254, 
R&D, Tocris) for 24h. The media was then completed replaced with differentiation media 
supplemented with 20 ng/ml BDNF (450-02-100, Peprotech) and 20 ng/ml GDNF (450-10-
100, Peprotech) and then 50% of the media was replenished every 2-3 days. Throughout the 
course of differentiation cultures were monitored and imaged routinely. At day 80 cells were 
harvested. The protocol for cortical neurogenesis was based on Shi et al. (Shi et al., 2012a; 
Shi et al., 2012b), but optimised for the iPSC model used.  
 
 
Membrane integrity assays 
Digitonin injury: Cells were treated with different concentrations of digitonin (0, 3, 5, 7, 10, 13, 
15, 17, 20, 25 and 30 μg/ml) for 10 or 20 min, as indicated. To measure membrane integrity 
upon digitonin permeabilization, cells were then incubated with 2.5μg/ml Hoechst-33342 
(H3570, Invitrogen) (Excitation 350, Emission 461) and 2 μg/ml propidium iodide (P4864, 
Sigma) (Excitation 535, Emission 617) and imaged using Celigo cytometer (Brooks Life 
Science Systems). Analysis was conducted using the Celigo Software Version 2.1 and 
biological triplicates were considered. Cell death percentage (i.e. the percentage of propidium 
iodide positive cells compared to the total number of cells) is a read-out of membrane 
permeability.  
 
Laser injury: Cells were kept at 37°C in cell imaging media and were treated with 1 mg/ml 
FM1-43 (Invitrogen T3163) and 2.5 µg/ml Hoechst 33258 (Sigma Aldrich 861405) immediately 
before injury. A 1-2 µm circular region was irradiated using a 355 nm UV ablation laser (Rapp 
OptoElectronic) with the following settings: 2.6 % power, 200 Hz repetition rate, pulse energy 
> 60 µJ, pulse length < 4 ns. Images were acquired with the inverted microscope Eclipse Ti-
E (Nikon) paired with the UltraVIEW VoX Spinning Disk (PerkinElmer) using the 63x objective. 
Cells were imaged for 350s (including at least 50s pre-injury). Control of hardware as well as 
intensity measurements were performed with PerkinElmers Volocity software. Plasma 
membrane integrity was measured by monitoring uptake of dye as a change in intracellular 





To identify the protein targets of CHIP two separate mass spectrometry screens were 
conducted on two CHIP cell models (iPSC and cortical neurons). In an attempt to account for 
the inherent variability of the cortical differentiation, the CHIP KO cortical neurons were 
compared to both control cell lines (the unedited parental line and a CRISPR/Cas9 clone 
expressing CHIP). For both screens biological and technical triplicates were included (of note, 
each biological replicate comprises of duplicate wells due to the minimum protein 




iPSC and mature cortical neurons (day 80) were imaged prior to harvesting and lysed on the 
cell culture plate with 8M urea, 50 mM Hepes pH 8, 100 mM KCl, 1mM DTT and 0.5% (w/v) 
n-Dodecyl-β-D-maltoside (compatible with mass spectrometry). Protein lysates were 
centrifuged at 14000 g/20 min/8°C and supernatant was subsequently transferred to clean 
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tubes. Protein concentration was assessed using the Micro BSA assay (ThermoFisher 
Scientific) according to the manufacturer’s instructions for the microplate procedure but 
optimised for minimal sample consumption. Samples were snap frozen in liquid nitrogen and 
stored at -80ºC.  
 
Cell lysates were processed using the filter-aided sample preparation (FASP) protocol, as 
described previously (Wiśniewski et al., 2009). Urea buffer (8 M Urea in 0.1 M Tris pH 8.5) 
was added to a 10 kD spin filter column (Sartorius Stedim Biotech, #VN01H02). Protein 
concentration was determined using the RC-DC assay (Bio-rad). Normalized sample (80-100 
μg) was added into the spin filter column and was centrifuged at 14000 g for 15 min at 20 °C. 
Urea buffer was added again with 100 mM Tris (2-carboxyethyl) phosphine hydrochloride 
(C4706, Sigma) and mixed, for protein reduction. The column was incubated for 30 min on a 
shaking thermo-block at 37ºC and 600 rpm and centrifugation for 15 min at 4,000 g and 20ºC. 
Free sulfhydryl groups were alkylated using 300 mM iodoacetamide in urea buffer (I6125, 
Sigma). Protein alkylation took place in the dark at room temperature for 20 min followed by 
another centrifugation at 14000 g for 15 min. Ammonium bicarbonate (100 mM) was added to 
the column followed by centrifugation at 14000 g for 20 min. The column was placed in a new 
low-binding collecting tube (Axygen) and 50 mM ammonium bicarbonate was added along 
with trypsin diluted in trypsin buffer (Promega) at a 1:50 ratio (w/w) (trypsin:protein). The 
sample was mixed at 600 rpm for 1 h and then incubated overnight in a humidified chamber 
at 37ºC. The peptides were eluted by centrifugation at 14,000 rom for 15 min at 20ºC. Samples 
within the same experiment were prepared simultaneously. 
 
Peptide concentration was measured using the Quantitative Colorimetric Peptide Assay 
(23275, Pierce, Thermo Scientific), following the manufacturer’s instructions. The absorbance 
of the reaction was measured using a TECAM spectrophotometer at 480 nm. Samples were 
desalted on C18 Micro spin columns (Harvard Apparatus) as described in (Bouchal et al., 
2009) and dried in a SpeedVac at 35ºC for 1 h or until no residual liquid is present. Samples 




Desalted tryptic peptides were dissolved in 100 μl of 5 % acetonitrile (ACN), 0.05 % TFA and 
the peptide concentration was determined using a NanoDrop (Thermo Scientific, MA, USA). 
Samples were diluted in order to load approximately 2 ug of peptides a 3.7 µl injection to 
column. Peptide samples were separated by liquid chromatograph using Eksigent Ekspert 
nanoLC 400 (SCIEX) online connected to a TripleTOF 5600+ mass spectrometer (SCIEX). 
Samples were pre-concentrated on a cartridge trap column (300 μm i.d. × 5 mm) packed with 
C18 PepMap100 sorbent with 5 μm particle size (Thermo Scientific) using a mobile phase 
composed of 0.05 % trifluoroacetic acid (TFA) in 2 % ACN. Pre-concentrated peptides were 
separated on a capillary analytical column (75 μm i.d. × 500 mm) packed with C18 PepMap100 
sorbent, 2 μm particle size (Thermo Fisher Scientific). Mobile phase A was composed of 0.1 
% (v/v) formic acid (FA) in water while mobile phase B was composed of 0.1 % (v/v) FA in 
ACN. The analytical gradient started from 2% B, the proportion of mobile phase B increased 
linearly up to 40% B in 120 min, with a flow rate of 300 nl/min. The analytes were ionized by 
a nano-electrospray ion source, where the temperature and flow rate of the drying gas was 
set to 150 °C and 12 psi. Voltage at the capillary emitter was 2.65 kV. Measurement of each 
biological replicate was repeated three times to give technical triplicates. SWATH-MS data 
were acquired in high sensitivity positive mode. Precursor range was set from 400 Da up to 
1200 Da and it was divided to 67 precursor SWATH windows with 12Da width and 1 Da 
overlap. Accumulation per SWATH windows was set to 50.9 ms resulting in a 3.5 sec cycle 
time was 3.5 sec. Product ions were scanned in a range from 360 to 1360 Da. Rolling collision 
energy setting with 15 mV collision energy spread was used. 
 
Data-dependent acquisition to generate an in-house spectral library 
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The spectral library sample was prepared by equimolar pooling of all samples. The spectral 
library was measured as described in (Faktor and Bouchal, 2016). Briefly, pooled spectral 
library samples were measured in information-dependent mode (IDA). Precursor range was 
set from 400 Da up to 1250 Da in MS mode and from 200 Da up to 1600 Da in MS/MS mode. 
Cycle time was set to 2.3 sec and during each cycle the top 20 most intensive precursor ions 
were fragmented. The precursor exclusion time was set to 12 sec. IDA data were searched 
against a Homo sapiens reference database (Uniprot+TrEmbl, 2016_02, 70005 entries) in 
ProteinPilot 4.5 (AB-SCIEX). The reference database contained decoy sequences of all 
proteins. Trypsin was set as a protease and carbamidomethyl was defined as a fixed 
modification. Tolerated mass error in MS1 and MS2 was set to predefined TripleTOF 5600 
settings. No emphasis to a particular variable modification was given. The FDR calculation 
was performed by searching the MS/MS data against the decoy database. A total of 2087 
proteins (FDR<1 %) and 8713 peptides (FDR<1 %) (see Table S2) were identified. The 
identified proteins and corresponding spectra from the resulting GROUP file were imported 
into SWATH™ Acquisition MicroApp 1.0 a plugin of PeakView 1.2.0.3. (AB-SCIEX) to 
generate a spectral library. A maximum of 4 peptides with no miscleavages, no post-
translational modifications and peptide confidence above 99% per protein were imported into 
the spectral library. Each peptide was represented by a maximum of 6 transitions. The 
resulting spectral library contained 1424 proteins (FDR<1 %) and out of these 1353 proteins 




SWATH-MS data extraction and statistical analysis:  
SWATH data analysis was performed in a software platform intended for SWATH data 
analysis developed by AB-SCIEX. Quantitative data extraction was performed in SWATH™ 
Acquisition MicroApp 1.0 plugin running under PeakView 1.2.0.3 (AB-SCIEX) with the in-
house spectral library prepared as described above. A maximum of 4 peptides per protein (if 
detectable) and a maximum of 6 product ions per peptide (if detectable) were used for protein 
quantitation. Quantitative SWATH-MS data were extracted using a method with ± 4 min 
extraction window around the expected retention time. The retention time window was 
determined based on retention time variability in the dataset. Product ion chromatograms of 
transitions were extracted ± 0.05 Da around the expected product ion mass. Peak areas for 
each transition were determined from extracted product ion chromatograms. Peak areas were 
further processed in MarkerView 1.2.1.1. (AB-SCIEX) on a peptide and protein level. The SRM 
like nature of SWATH-MS data enabled the determination of summed intensities per each 
protein by summing corresponding transition peak areas. Summed protein intensities were 
normalised on total ion current in MarkerView software. A t-test function in MarkerView 
software was used to perform pairwise t-testing of summed protein peak areas across 
compared conditions. The confidence of detected differences in a protein expression level 
between conditions (e.g. CHIP WT vs. CHIP KO) are described by p-value determined in 
MarkerView. The data were normalized by using of DESeq2 package (Love et al., 2014) 
implemented in R (R-Core-Team, 2018). Results were visualized in heatmaps by pheatmap 




To identify GO terms (biological processes, molecular functions and cellular components) 
associated with the SWATH-MS datasets were analysed by GOrilla (Eden et al., 2007; Eden 
et al., 2009), Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang 
et al., 2009a, b) and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 
(Szklarczyk et al., 2019) gene ontology analysis software. These bioinformatic tools use 
different statistical parameters and reference databases to identify associated GO terms. 
 
 27 
To obtain GO terms using GOrilla (http://cbl-gorilla.cs.technion.ac.il/), a background list and 
target set is created from each SWATH-MS analysis (only gene symbols are included). The 
former includes all proteins identified, while the target set includes significantly changes 
proteins (having a fold change ≤0.67 and ≥1.5). The enrichment score for each GO term is 
calculated by a hypergeometric distribution: (b/n)/(B/N), where N is the total number of genes, 
B is the number of genes associated with a specific GO term, n is the number of entries in the 
target set and b is the number of entries in the target set that are associated with a specific 
GO term. In addition to the enrichment score, the enrichment p-value is also generated for 
each GO term, which describes the probability of observing that b or more entries in the target 
set are associated with a given GO term, under the null assumption that all GO term 
occurrence in a ranked list are equiprobable (Eden et al., 2009). Also, an adjusted p-value 
using the FDR approach (q-value) is given and a threshold of 0.05 is considered significant. 
GO terms and their p-values derived from GOrilla were represented graphically using the 
REduce + VIsualize Gene Ontology (REVIGO) software (http://revigo.irb.hr/) (Supek et al., 
2011). Graphs show GO terms identified from P/KO and WT/KO SWATH-MS analyses. When 
a particular GO term is found in both datasets, the average p-values was plotted. GO terms 
plotted are colour-coded depending on their Log10(p-value).  
 
Like GOrilla, DAVID (https://david.ncifcrf.gov/tools.jsp) searches for significantly associated 
GO terms using both a background list and a target set (proteins with ≤0.67 and ≥1.5 fold 
changes). However, DAVID differs from GOrilla because it allows exact fold changes for each 
protein to be included in the datasets (a feature that was used in our study). When looking at 
membrane proteins specifically, non-significant and significant membrane proteins were 
included in these datasets (using the same fold change cut-off criterium). For each GO term 
identified the following is given: (1) number of entries from the input list that are involved in a 
term (“count”), (2) gene-enrichment analysis presented as a Modified Fisher Exact p-value 
that ranges from 0 (corresponding to a perfect enrichment) to 1 (“p-value”), and (3) an adjusted 
p-value using Benjamini (“Benjamini”).  
 
The Functional Enrichment Analysis tool of STRING was also used to identified significantly 
associated GO terms with the input dataset. Unlike previous platforms discussed, all proteins 
identified and their fold changes were taken into account when using STRING. Homo sapiens 
origin was selected. For each GO terms identified an Enrichment score and FDR are 
calculated (a threshold of 0.05 is considered). The software also uses hypergeometric testing 
and eleven functional pathway classification frameworks (Szklarczyk et al., 2019).   
 
For pathway analysis and predictions of upstream regulators, the Ingenuity Pathway Analysis 
(IPA) software (Qiagen) was used. Predictive canonical pathway and upstream regulator 
analyses were performed using the following cut off: -log(p-value) > 1.3 (which corresponds 
to p-values of <0.05). Z-scores reflect the predicted activation state of the pathway or potential 
upstream regulator (a positive/negative z-score indicates activation/inhibition). At its basis, the 
observed protein expression changes (identified by MS) are associated to molecular networks 
and literature-derived regulation direction (activation/inhibition). Z-scores rather than p-values 
were included because they reflect directionality. This is a significant advance compared to 
other pathway analysis tools, which just focus on statistical enrichment in an overlap set of 
genes (Krämer et al., 2014). Of note, this software was also used to isolate membrane proteins 
from all the SWATH-MS data.  
  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Quantitative reverse transcription PCR (qRT-PCR) was performed in biological duplicates and 
technical triplicates. Relative levels of transcript expression were quantified by the 
comparative CT method with normalisation to TBP levels.  
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Quantification of SWATH-MS data and the statistical parameters used are described in the 
section “SWATH-MS analysis” under Method Details. Biological triplicates (each are a pool of 
duplicates) and technical triplicates were included.  
 
Membrane integrity was assessed by quantifying the intracellular fluorescence of proprium 
iodide or FM4-64 dye (added extracellularly) upon injury by digitonin or UV laser, respectively. 
The number of cells injured by digitonin were represented as a percentage of all cells 
quantified. Mean ± SD of biological triplicates were plotted and were representative of three 
independent experiments. Data passed the D’Agostino-Pearson normality test (alpha=0.05) 
and was analysed by two-way ANOVA with Holm-Sidak’s multiple comparison post-hoc test. 
With regards to cells injured by UV laser, the intracellular fluorescence intensity (F) changes 
over time were analysed by calculating the mean of the normalized intensity values (FΔ/F0) 
as a function of time for each cell body (n ≥ 16 cells), yielding area under the curve (AUC) 
values. Data passed the D’Agostino-Pearson normality test (alpha=0.05) and a Student’s t-
test was performed on the AUC values of both cell lines (CHIP KO and WT) under the null 
hypothesis that changes in fluorescence intensities over time are the same for different 
groups. Mean ± SEM was plotted. Quantification of fluorescence intensity was performed 
using the Volocity software. 
 
Normality tests and statistical analysis were performed using GraphPad Prism 8 (GraphPad 
software, Inc.). Statistical tests used and p values are detailed in figure legends (Fig. 1I, Fig. 
2F and Fig. 4H, I & K), with significance established at p value < 0.05. Graphs and illustrations 
were performed with GraphPad Prism and Illustrator software (Adobe). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




